Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin.
Indu DharSumia SiddiqueEva R PedersenGard F T SvingenVegard LysneThomas OlsenDennis W NilsenJan Erik NordrehaugØivind MidttunPer M UelandGrethe S TellOttar K NygårdPublished in: Heart (British Cardiac Society) (2020)
In patients with suspected SAP, the majority of whom receiving statin therapy, high plasma neopterin was associated with increased risk of AMI particularly among those with low LDL-C and apoB100 or high Vit-A levels. The particularly strong relationship of plasma neopterin with residual cardiovascular risk in patients with low lipid levels should be further investigated.